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In planning for a large-scale multicenter trial to evaluate the effect of acupuncture for the treatment of lateral elbow pain, a pilot
study was conducted. This was a prospective, investigator- and patient-blinded, nonrandomized, placebo controlled trial. Subjects
were evaluated at baseline, before fourth, seventh, and ninth treatment, and at a two-week posttreatment follow-up. The treatment
group received unilateral acupuncture at LI 10 and LI 11 at the affected side with manual needle manipulation; the control group
received sham-laser acupuncture at the same acupoints. Measures included (i) disabilities of the arm, shoulder, and hand (DASH)
questionnaire, (ii) pain-free grip strength (PFGS), and (iii) a visual analogue scale (VAS) for pain. Significant differences in DASH
score, PFGS, and VAS between treatment and control group were found at the ninth treatment (𝑛 = 20 for each group, 𝑃 <
0.05). Only DASH showed significant differences compared to the control for all the measurement time points after treatment
commenced and appears to be a sensitive and appropriate primary outcome measure for the future multisite trial. Results from
this pilot study provided relevant information about treatment efficacy, credibility of control treatment, and sensitivity of different
outcome measures for the planning of the future trial.
1. Introduction
Background. Acupuncture has been used for the treatment
of many musculoskeletal conditions, including lateral elbow
pain (LEP), or tennis elbow. However, a high level of evidence
supporting the use of acupuncture treatment for LEP is
lacking [1–4]. In our latest review of the topic, we have
found some evidence suggesting that acupuncture might
be more effective than sham acupuncture or ultrasound
treatment. However, it was also found that there are many
limitations associatedwith the previous studies, such as a lack
of standardization of outcome measures, no clear statement
of primary outcome measure, and much variation in the
administration of acupuncture and in the selection of a
control treatment [2].
We have planned to conduct a four-site trial in four coun-
tries/regions to determine the efficacy of acupuncture treat-
ment for LEP, with the goal to minimize limitations of pre-
vious studies. Multisite randomized controlled trials (RCTs)
are commonly used in pharmaceutical studies, as they have
the ability to capture larger sample sizes and their findings
are more generalizable than the findings of single-site RCTs.
Moreover, multisite RCTs can facilitate the adaptation of best
practice in the selection of treatment protocols and outcome
measures, as there are a larger number of experienced
researchers involved in the design and execution of the trial.
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The selection of a treatment regime is challenging as
positive results have been reported for manual needling,
electroacupuncture, andmanual acupuncture combinedwith
moxibustion [5–7]. Within manual needling there are also
many variations in the needling technique. Similarly, different
outcome measures have been used to evaluate the efficacy
of treatment for LEP, including pain, functional impairment,
and grip strength [5, 8, 9]. In view of the need to establish an
easy-to-replicate method of acupuncture treatment for LEP,
it was decided to trial a simple manual needle manipulation
technique that has been used by Fu-Chun Wang, one of the
experts in our study group. In our planning meeting it was
apparent that a pilot study was needed to assess the adequacy
of the initial treatment protocols and outcome measures.
Objectives. Through the pilot study it was hoped to gain
some information regarding the following: first, we wanted
to observe the efficacy of the selected acupuncture treatment
protocol. Second, we wanted to know which outcome mea-
sure was sensitive and could be used in the future multisite
trial as the primary outcome measure. Third, we wanted to
gather information on the standard deviation of the primary
outcome measure in the studied population, which would
be crucial for determining the sample size of the multisite
trial. Finally, we wanted to determine the credibility of
the control intervention, which was a sham-laser treatment
(deceptive nonactive laser treatment). To this end, a two-arm,
nonrandomized study using sham-laser treatment as control
was undertaken at one of the study sites. Randomization of
subjects was not performed due to a time constraint because
the laser unit was not available at the beginning of the trial.
2. Methods
2.1. Trial Design. This study was designed to be a care-
provider-, assessor-, and patient-blinded, nonrandomized
(group allocation in two blocks based on the time the subject
entered screening), placebo controlled (sham-laser), parallel
arm trial to evaluate the efficacy of acupuncture in the
treatment of LEP.This trial specifically served as a pilot study
to test the efficacy of the treatment protocol and the suitability
and sensitivity of the outcomemeasures and to serve as a basis
to determine the sample size of a much larger, multicentered,
international RCT (tennis elbow acupuncture international
study, China, Hong Kong, Australia, and Italy: TEAISCHAI).
2.2. Subjects. This study took place from February 2012
until December 2012 and the protocol was approved by the
Changchun University of Traditional Chinese Medicine and
adhered to the Declaration of Helsinki [10]. The study was
advertised in the press and subjects were instructed to contact
the research team via telephone. Prescreening was carried out
by means of a semistructured telephone interview. Subjects
were mainly referred from the outpatient department of the
ChangchunUniversity of Traditional ChineseMedicine Hos-
pital. As a result of this, 53 subjects who appeared to be suit-
able for enrolment were invited for screening. After careful
screening through history taking and clinical examination for
inclusion and exclusion criteria, 41 subjects were selected and
enrolled in the trial after they had given informed consent.
Inclusion criteria were adult population from 18 to 70 years
with a history of unilateral chronic elbow pain for over three
months.We excluded subjects who had a history of central or
peripheral nervous system disease, inflammatory rheumatic
diseases, radial nerve entrapment, radioulnar or radio-
humeral osteoarthritis, gout, earlier episodes of lateral elbow
pain treated surgically, earlier episodes of lateral elbow pain
treated with acupuncture within the previous six months, or
acupuncture treatment for any problems within the previous
week. Subjects with pregnancy or needle phobia were also
excluded.The diagnostic criteria for lateral epicondylitis were
the following: (i) typical history of lateral elbow pain, (ii)
tenderness and pressure pain on the radial epicondyle of the
humerus (insertion of common extensor tendon), and (iii)




Rationale. We based the acupuncture point selections on
Traditional Chinese Medicine meridian theory [11], fre-
quently recommended points to treat LEP [12], and the
consensus found during an initial meeting of all centers of the
TEAISCHAI study. Special attention was given to the needle
stimulation technique, whichwas based on the “green dragon
wags its tail” method originating from the Zhen Jiu Da Quan
(Complete Book of Acupuncture-Moxibustion) [13], as well
as over 30 years of clinical experience from Fu-Chun Wang,
one of our experts on needling techniques.
Standardized interventions were developed for both
treatment and control groups. Interventions did not vary
within one group and all subjects receive the same interven-
tion at all treatment sessions for their group. Practitioners
were required to apply standardized intervention protocols
to subjects, dependent on the participant’s group identity.
Needling Details. Two acupoints LI 11 (Quchi) and LI 10
(Shousanli) were needled with single-use, stainless steel, ster-
ile, filiform 0.30mm × 40mm Hua Tuo needles unilaterally
on the effected side per subject per treatment session. They
were located according to the “WHO Standard Acupuncture
Point Locations in theWestern PacificRegion” (WorldHealth
Organization 2008) [14]. LI 11 (Quchi) was needled first,
perpendicular insertion up to 1.5 cun was performed, and
then the needle was withdrawn to one-cun depth. Then LI
10 (Shousanli) was needled; oblique insertion at 45∘ pointing
towards the elbow was performed to a depth of one cun.
Needling sensation (Deqi) was sought on both acupoints.
Muscle twitch was recorded on subject’s daily reporting sheet
if achieved. Manual needle manipulation was used. For LI 11
(Quchi) the practitioner held the needle on the end of the
handle and bent it 45∘ left and right with a speed of one
Hz for two minutes or according to participant’s tolerance.
This procedure was then repeated for LI 10 (Shousanli) and
was again repeated for both acupoints prior to removing the
needles. Needles were retained in situ for 25 minutes.
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Treatment Regimen. For both, the treatment and the control
group, each intervention session lasted 25 minutes. Subjects
were asked to attend three sessions per week (Monday,
Wednesday, and Friday) for three weeks, totaling nine ses-
sions during the entire trial period.
Other Components of Treatment. There were no other inter-
ventions administered to either group. However, subjects
using analgesics, NSAIDs, or exercise programs within the
last two weeks prior to commencing the trial were requested
to maintain their current regime but needed to keep a record
in their diary.
Treatments were undertaken at the outpatient depart-
ment of Changchun University of Traditional Chinese
Medicine Hospital. Video and hard copy instructions were
prepared to train practitioners to ensure standardization of
interventions. Subjects were well informed about the study
interventions.
Practitioner Background. The practitioner delivering the
interventions was a qualified acupuncturist with a minimum
of seven-year clinical practice. The clinician was competent
and familiar with the relative treatment protocol.
2.3.2. Control Intervention
Rationale. Placebo acupuncture control interventions (sham
acupuncture) have not yet been standardized and there is
no agreed consensus within the scientific community on
which sham acupuncture method should be used [15]. We
therefore refrained from inserting needles, whichmight cause
a microinjury and might trigger a cascade of physiologic
reactions, and used an inactive laser unit instead.
Laser Details. The inactive laser unit was rested lightly on the
skin at the same acupoints as the treatment group. Firstly,
the subject was told that LI 11 (Quchi) was treated for two
minutes, after which the subject was asked to rest for ten
minutes, and then LI 10 (Shousanli) was treated for two
minutes, after which the subject was asked again to rest for
ten minutes. The entire procedure took 24 minutes.
The laser unit (H6 N6 Laser Acupuncture Instrument,
Model HY369-B) had the laser diode replaced by an LED
light and a sound upon switching it on and off indicated
functionality. Participants were warned about the “harmful-
ness” of the laser to the eyes, and the laser was held away
from the participants’ eyes at all times. The participants as
well as the practitioner were asked to wear special laser-
protection glasses during the course of the intervention. The
intervention regimen (duration, number, and frequency of
intervention sessions) was the same as for the treatment
intervention.
A credibility rating scale [16] was used to identify the
credibility and adequacy of the control intervention. After
allocation but prior to the first intervention, the intervention’s
credibility rating scale (CRS) was administered to each
subject regardless of group identity. Participants were asked
to choose the most suitable answer for four statements on a
five-point scale. The four statements were as follows: (i) “My
illness will improve considerably”; (ii) “I will be able to better
cope with my illness”; (iii) “The condition’s symptoms will
disappear”; (iv) “My mental state will improve because of the
intervention.” Zero points on the CRS indicated that subjects
expected no efficacy, one point indicated little efficacy, two
points indicatedmediumefficacy, three points indicated good
efficacy, and four points indicated that subjects expected to be
fully cured due to the intervention that they would receive.
2.4. Outcome Parameters. Prior to initial interventions, (i)
demographic data (gender, age, and duration of condition),
(ii) disabilities of the arm shoulder and hand (DASH) score,
(iii) pain-free grip strength (PFGS), and (iv) pain, using a
visual analogue scale (VAS), were obtained.
During the nine intervention visits DASH, PFGS, and
VAS were assessed four times: prior to the first, fourth,
seventh, and ninth visit. During a follow-up visit two weeks
after the last (ninth) intervention, the outcome measures of
DASH, PFGS, and VAS were reassessed at which point the
study ended. The outcome assessor was blinded with respect
to the subject’s group identity and had no knowledge which
intervention technique was applied.
The DASH questionnaire was used to assess functional
impairment of the elbow [17]. Subjects were asked to answer
all 30 questions of the main module, not including the two
optional models.
Muscle strength (PFGS) was assessed using a hand held
dynamometer (model J00105 JAMAR), while the subject was
seated on an armchair with the forearms supported by the
arm of the chair and the wrists just over the end of the
chair, forearms semipronated, wrists in neutral position, and
thumbs facing upwards. Three measurements were taken for
both arms with ten to twenty seconds rest in between each
measurement.Themean of the threemeasurements was used
for analysis. Subjects were asked to squeeze as long and as
tight as possible but to stop squeezing if they felt pain. PFGS
is considered a valid and reliable outcome measure for LEP
[18].
Pain assessment was conducted by using a pain-
monitoring questionnaire consisting of a 100mm long non-
segmented line (VAS). Subjects were asked to indicate with an
“𝑥” across a vertical line the level indicating their pain at rest,
in motion, and during exertion, starting from 0mm, no pain
at all, to 100mm, excruciating pain. VAS has been frequently
used in pain evaluation studies and has been found to be
a reliable and valid measurement with the LEP population
[5, 19, 20].
Adverse events were to be noted and reported by the
practitioner.
2.5. Allocation and Blinding. Subjects were allocated to either
treatment or control group based on when they entered the
screening phase. During the first screening phase twenty-one
subjects were enrolled in the treatment group. The second
screening phase was terminated after 20 subjects enrolled
in the control group. Subjects, care-providers, and assessors
were blinded with respect to the efficacy of the control
intervention. That is, even though subjects obviously knew
that they received laser treatment instead of acupuncture,
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they were not aware that the laser unit was inactive. Likewise,
the care-provider and assessor were not aware that the laser
diode was replaced with an LED light. Guo-Xue Zhang
screened and enrolled the subjects and provided treatment.
Hao Liu conducted the outcome assessments; both were
blinded. Yan-Song Liu was not blinded, coordinated the trial,
and assigned which of the two blocks would receive which
intervention.
2.6. Statistical Analysis. Statistical analysis was performed
using the statistical package for the social sciences (SPSS)
version 21. Distribution of data was tested by (a) numerical
methods and (b) graphical methods. Numerical methods
included (i) assessment of 𝑧-scores for skewness and kurtosis
and (ii) the Shapiro-Wilk’s test for both groups. Visual
methods included (i) visual inspection of histograms and (ii)
visual inspection of normal Q-Q plots for both groups.
Mann-Whitney 𝑈 tests were performed for baseline,
credibility rating, and between-group analyses. Pairwise
comparisons of DASH scores, PFGS, and VAS at rest, in
motion, and during exertion were performed with a Bonfer-
roni correction for multiple comparisons. To determine the
difference between the two groups, we compared the mean
differences relative to baseline instead of the actual mean
values to compensate for baseline differences between the two
groups. Distributions of scores for both groups were assessed
by visual inspection. If distributions were of similar shape,
medians were compared. If distributions were of dissimilar
shape, mean ranks were compared.
For within-group analysis we used Friedman’s two-way
analysis of variance by ranks test comparing median DASH
scores, PFGS, andVAS at rest, inmotion, and during exertion
at a given time point with the respective baseline value.
Pairwise comparisons were performed with a Bonferroni
correction for multiple comparisons.
3. Results
Normality tests showed that the majority of the data was not
normally distributed and could not be transformed to meet
assumptions for parametric tests; therefore nonparametric
tests for data analysis were performed.
Out of the 53 subjects initially assessed for screening,
seven were excluded because they did not meet the inclusion
and exclusion criteria, three refused to participate, because
of fear of needling, and two refused after they were given
detailed information about the trial, because they could not
find enough time. Forty-one subjects entered the trial and
were allocated to either treatment group (𝑛 = 21) or control
group (𝑛 = 20). One subject did not attend the course of
treatment and thus was not included in the analysis. Figure 1
shows the details of the trial participants and their progress
through the stages of the trial according to the CONSORT
statement [21].
Baseline information of the subjects is reported in Table 1.
Independent samplesMann-Whitney𝑈 tests showed that the
two groups’ demographic characteristics as well as baseline
measurements of DASH, PFGS, and VAS were all similar,
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Figure 1: Flow chart trial participants.





Male (%) 11 (55) 8 (40)
Female (%) 9 (45) 12 (60)
Total 20 20
Age (mean ± SD) 42 ± 16.68 50.65 ± 7.27
Duration of condition (mean ± SD) 7.45 ± 6.09 9.45 ± 3.49∗
DASH (mean ± SD) 26.03 ± 7.61 21.79 ± 11.56
PFGS (mean ± SD) 16.54 ± 7.29 19.12 ± 9.15
VAS at rest (mean ± SD) 2.34 ± 1.28 1.65 ± 1.16
VAS in motion (mean ± SD) 3.96 ± 1.42 4.03 ± 1.31
VAS during exertion (mean ± SD) 6.62 ± 1.72 7.25 ± 1.62
∗: 𝑃 = 0.047, significant difference between treatment and control group.
rank = 24.15) which was significantly higher than the treat-
ment group’s (mean rank = 16.85) (𝑃 = 0.047).
The results of the credibility rating scale are shown in
Figure 2. No significant differences in efficacy expectancy
between the two groups were found (e.g., improvement of
condition expectancy, 𝑃 = 0.71, Mann-Whitney 𝑈 test).
This suggests that participants rated the control intervention
(sham-laser) as a highly credible form of treatment in this
current setting.





























































































Figure 2: Credibility assessment comparing treatment and control
interventions using a five-point rating scale (𝑛 = 20 for each group).
Histograms display means, error bars show standard deviations
(SD), and no significant difference between groups was found.
There were significant within-group differences for all
measurements in the acupuncture group when comparing
the last treatment (ninth treatment) and the two-week follow-
up visit with the baseline (Friedman’s test) (see Table 2). For
DASH, VAS at rest, and VAS during exertion, statistically
significant differences were observed as early as the seventh
treatment visit (Table 2).
We found significant differences in the control group
when comparing baseline to the ninth and the two-week
follow-up visit for DASH scores and for VAS during exertion.
Significant difference was also found between baseline and
the seventh visit for PFGS measurements. For other time
points of DASH, PFGS, and VAS during exertion, no signif-
icant differences were found. There were also no significant
differences between baseline and any time point for VAS at
rest and VAS in motion in the control group (Table 2).
Mann-Whitney 𝑈 tests were run to determine if there
were differences in improvement from the baseline value at
a given time point between the two groups. We found sig-
nificant differences in functional impairment (DASH scores)
already from the fourth visit to the follow-up visit. Formuscle
strength (PFGS) significant differences were observed from
the seventh visit onwards. Pain at rest (VAS rest) and pain in
motion (VASmotion) showed significant differences between
the two groups from the last (ninth) treatment visit onwards.
Pain during exertion (VAS exertion) significantly improved
from the seventh visit onwards (Figures 3(a), 3(b), 3(c1), 3(c2),
and 3(c3)).
No adverse events were reported.
4. Discussion
The present study was designed to serve as a pilot for a
multisite international trial to evaluate the effectiveness of
acupuncture treatment for tennis elbow. We found that the
acupuncture treatment was efficacious compared to sham-
laser treatment. At the end of the treatment and at two-week
posttreatment, subjects in the acupuncture group showed
significant differences in all outcome measures compared to
the control group.These pilot results suggest that the manual
acupuncture procedure is efficacious and can be used for a
large multisite trial. Furthermore, we found that the control
treatment was as credible as the acupuncture treatment to the
subjects, although the procedure of sham-laser treatment was
distinctly different from manual acupuncture. Similar credi-
bility of sham-laser treatment has been reported previously
[22].
Many different types of control have been used in
acupuncture trials, but there has been no consensus as to
which type is the best [23]. Recently, it has been argued that
sham acupuncture is not an inert placebo [24], and there
is evidence that some types of sham acupuncture produce
physiological activity that are not due to a placebo effect [25,
26]. By usingmock laser as control, we believe to have avoided
the possible biological reactions to sham acupuncture. On the
other hand, we believe that mock laser stimulation is just as
valid as the usual sham acupuncture to be used as control,
because it also has placebo effects. For example, we have
previously found that both electroacupuncture and mock
laser stimulation have similar efficacy in a large-scale clinical
trial for neck pain [27].
Of the various outcome measures, only DASH showed
significant difference compared to the control for all the
measurement time points after the treatment commenced.
Since DASH is a comprehensive evaluation of function rather
than just pain, it appears to be a sensitive and appropriate
measure to be used as the primary outcome measure for a
future study. Thus, the DASH data from this pilot study will
enable the estimation of an adequate sample size for a large-
scale, multisite international trial.
A significant drawback of this study was the fact that the
two groups of subjects entered into the trial at different time
periods and that they were not randomized. This exposed
our results to several confounding factors, such as cohort
difference and seasonal changes. Therefore, when using our
results for planning the future multisite trial, one should
use the current data cautiously for sample size calculation.
Another limitation of this study was that we only included
subjects with unilateral elbow pain, which may lead to
limitation in the generalizability of the results.
5. Conclusion
In conclusion, results from this pilot study have provided
basic information about treatment efficacy, credibility of
control treatment, and sensitivity of different outcome mea-
sures. This information has enabled us to plan for a large-
scale, multisite trial to properly evaluate the effectiveness of
acupuncture treatment for LEP.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(a) Change of DASH score (b) Change of PFGS (kg)
(c2) Change of pain in motion (VAS, cm) 
∗ ∗



















(c3) Change of pain during exertion (VAS, cm)
∗∗ ∗
Baseline 4th 7th 9th 2w after treatment










Figure 3: DASH and PFGS changes over time. Line graphs showing changes of the two groups from baseline throughout the trial period
for (a) disabilities of the arm, shoulder, and hand (DASH) score (functional impairment) and (b) pain-free grip strength (PFGS) (𝑛 = 20 for
each group). Error bars show standard deviations (SD); ∗: statistically significant difference (𝑃 < 0.05) between the two groups at a given
time point. (c1)–(c3) VAS changes over time. Line graphs showing changes of the two groups from baseline throughout the trial period for
(c1) pain at rest, (c2) pain in motion, and (c3) pain during exertion on visual analogue scales (VAS) (𝑛 = 20 for each group). Error bars show
standard deviations (SD); ∗: statistically significant difference (𝑃 < 0.05) between the two groups at a given time point.
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